tm logo

Monitor this mark

View On USPTO

HEMJENA
Live/Registered
REGISTERED

on 30 Aug 2022

Last Applicant/ Owned by

bluebird bio, Inc.

Somerville MA 02145

Serial Number

79311185 filed on 26th Feb 2021

Registration Number

6829674 registered on 30th Aug 2022

in the Principal Register

Correspondent Address

Christopher K. Albert

Christopher K. Albert Hamilton, Brook, Smith & Reynolds, P.C.

Concord, MA 01742-9133

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

HEMJENA

Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79311185

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 5309.0070004

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
13th Sep 2024NEW REPRESENTATIVE AT IB RECEIVED
23rd Dec 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
03rd Jan 2023FINAL DECISION TRANSACTION PROCESSED BY IB
09th Dec 2022FINAL DISPOSITION NOTICE SENT TO IB
08th Dec 2022FINAL DISPOSITION PROCESSED
30th Nov 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30th Aug 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
30th Aug 2022REGISTERED-PRINCIPAL REGISTER
26th Aug 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
14th Jun 2022PUBLISHED FOR OPPOSITION